Baird Medical Investment Holdings Limited
BDMD · NASDAQ
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $8 | $24 | $13 | $20 |
| % Growth | -66.7% | 81.9% | -34% | – |
| Cost of Goods Sold | $1 | $3 | $2 | $2 |
| Gross Profit | $7 | $21 | $11 | $18 |
| % Margin | 82.1% | 88.5% | 87.5% | 89% |
| R&D Expenses | $7 | $4 | $2 | $2 |
| G&A Expenses | $0 | $4 | $3 | $6 |
| SG&A Expenses | $10 | $7 | $4 | $7 |
| Sales & Mktg Exp. | $0 | $3 | $1 | $1 |
| Other Operating Expenses | $0 | $0 | -$0 | -$0 |
| Operating Expenses | $17 | $11 | $6 | $9 |
| Operating Income | -$10 | $10 | $5 | $9 |
| % Margin | -131.3% | 42.8% | 38.7% | 44.5% |
| Other Income/Exp. Net | -$0 | -$1 | -$0 | $1 |
| Pre-Tax Income | -$11 | $9 | $5 | $9 |
| Tax Expense | $1 | $1 | $0 | $1 |
| Net Income | -$11 | $8 | $4 | $8 |
| % Margin | -141.9% | 34% | 33% | 41.3% |
| EPS | -0.43 | 0.38 | -0.318 | 0.38 |
| % Growth | -213.2% | 219.5% | -183.7% | – |
| EPS Diluted | -0.43 | 0.38 | -0.318 | 0.38 |
| Weighted Avg Shares Out | 26 | 22 | 7 | 5 |
| Weighted Avg Shares Out Dil | 26 | 22 | 7 | 5 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$10 | $11 | $6 | $9 |
| % Margin | -121.3% | 45.1% | 43.3% | 47.6% |